Ascendance Biomedical Report issue

For profit Phase 1
Founded: Washington DC United States (2017)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2017
NCT03178695
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now